Literature DB >> 11867827

Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants.

W Anees1, V Huggins, I D Pavord, A S Robertson, P S Burge.   

Abstract

BACKGROUND: Despite having a work related deterioration in peak expiratory flow (PEF), many workers with occupational asthma show a low degree of within day diurnal variability atypical of non-occupational asthma. It was hypothesised that these workers would have a neutrophilic rather than an eosinophilic airway inflammatory response.
METHODS: Thirty eight consecutive workers with occupational asthma induced by low molecular weight agents underwent sputum induction and assessment of airway physiology while still exposed at work.
RESULTS: Only 14 (36.8%) of the 38 workers had sputum eosinophilia (>2.2%). Both eosinophilic and non-eosinophilic groups had sputum neutrophilia (mean (SD) 59.5 (19.6)% and 55.1 (18.8)%, respectively). The diurnal variation and magnitude of fall in PEF during work periods was not significantly different between workers with and without sputum eosinophilia. Those with eosinophilia had a lower forced expiratory volume in 1 second (FEV1; 61.4% v 83% predicted, mean difference 21.6, 95% confidence interval (CI) 9.2 to 34.1, p=0.001) and greater methacholine reactivity (geometric mean PD20 253 microg v 1401 microg, p=0.007). They also had greater bronchodilator reversibility (397 ml v 161 ml, mean difference 236, 95% CI of difference 84 to 389, p=0.003) which was unrelated to differences in baseline FEV(1). The presence of sputum eosinophilia did not relate to the causative agent, duration of exposure, atopy, or lack of treatment.
CONCLUSIONS: Asthma caused by low molecular weight agents can be separated into eosinophilic and non-eosinophilic pathophysiological variants with the latter predominating. Both groups had evidence of sputum neutrophilia. Sputum eosinophilia was associated with more severe disease and greater bronchodilator reversibility but no difference in PEF response to work exposure.

Entities:  

Mesh:

Year:  2002        PMID: 11867827      PMCID: PMC1746281          DOI: 10.1136/thorax.57.3.231

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

Authors:  S E Wenzel; L B Schwartz; E L Langmack; J L Halliday; J B Trudeau; R L Gibbs; H W Chu
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

2.  Induced sputum cell counts in healthy adults.

Authors:  J Belda; R Leigh; K Parameswaran; P M O'Byrne; M R Sears; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

3.  Induced sputum cellularity. Reference values and distribution in normal volunteers.

Authors:  A Spanevello; M Confalonieri; F Sulotto; F Romano; G Balzano; G B Migliori; A Bianchi; G Michetti
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

4.  Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff.

Authors:  A Vyas; C A Pickering; L A Oldham; H C Francis; A M Fletcher; T Merrett; R M Niven
Journal:  Occup Environ Med       Date:  2000-11       Impact factor: 4.402

5.  Development of an expert system for the interpretation of serial peak expiratory flow measurements in the diagnosis of occupational asthma. Midlands Thoracic Society Research Group.

Authors:  P S Burge; C F Pantin; D T Newton; P F Gannon; P Bright; J Belcher; J McCoach; D R Baldwin; C B Burge
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

6.  Rapid method for measurement of bronchial responsiveness.

Authors:  K Yan; C Salome; A J Woolcock
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

7.  Neutrophilic inflammation in severe persistent asthma.

Authors:  A Jatakanon; C Uasuf; W Maziak; S Lim; K F Chung; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

8.  Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma.

Authors:  J Côté; S Kennedy; M Chan-Yeung
Journal:  J Allergy Clin Immunol       Date:  1990-03       Impact factor: 10.793

9.  Peak flow rate records in the diagnosis of occupational asthma due to isocyanates.

Authors:  P S Burge; I M O'Brien; M G Harries
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

10.  Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

Authors:  P G Gibson; J L Simpson; N Saltos
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

View more
  21 in total

1.  Neutrophil airway inflammation in childhood asthma.

Authors:  C M McDougall; P J Helms
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  Non-eosinophilic asthma and the innate immune response.

Authors:  Ian D Pavord
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

3.  Fractional exhaled nitric oxide in the interpretation of specific inhalational challenge tests for occupational asthma.

Authors:  Gareth I Walters; Vicky C Moore; Emmet E McGrath; Sherwood Burge
Journal:  Lung       Date:  2014-02       Impact factor: 2.584

4.  An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.

Authors:  Jean-Luc Malo; Susan M Tarlo; Joaquin Sastre; James Martin; Mohamed F Jeebhay; Nicole Le Moual; Dick Heederik; Thomas Platts-Mills; Paul D Blanc; Olivier Vandenplas; Gianna Moscato; Frédéric de Blay; André Cartier
Journal:  Ann Am Thorac Soc       Date:  2015-07

Review 5.  Novel approaches to the management of noneosinophilic asthma.

Authors:  Neil C Thomson
Journal:  Ther Adv Respir Dis       Date:  2016-02-28       Impact factor: 4.031

6.  Semaphorin3E/plexinD1 Axis in Asthma: What We Know So Far!

Authors:  Latifa Koussih; Abdelilah S Gounni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Eosinophilic and Noneosinophilic Asthma.

Authors:  Tara F Carr; Amir A Zeki; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

Review 8.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

9.  Airways disease: phenotyping heterogeneity using measures of airway inflammation.

Authors:  Salman Siddiqui; Christopher E Brightling
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

10.  Airway inflammation in aluminium potroom asthma.

Authors:  T Sjåheim; T S Halstensen; M B Lund; Ø Bjørtuft; P A Drabløs; D Malterud; J Kongerud
Journal:  Occup Environ Med       Date:  2004-09       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.